Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?

COPD patients prescribed inhaled corticosteroids (ICS) outside guidelines should be targeted for ICS withdrawal. Within a primary care population of 209,618 we used a combination of digital search algorithm, individual record review, and clinical review to identify COPD patients suitable for a trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Harries, Timothy H, Gilworth, Gill, Corrigan, Christopher J, Murphy, Patrick B, Hart, Nicholas, Thomas, Mike, White, Patrick T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978678/
https://www.ncbi.nlm.nih.gov/pubmed/32021138
http://dx.doi.org/10.2147/COPD.S238239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978678/
https://www.ncbi.nlm.nih.gov/pubmed/32021138
http://dx.doi.org/10.2147/COPD.S238239

Ejemplares similares